Cargando…

Recombinant activated factor VII treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, and efficacy and safety outcomes

Detalles Bibliográficos
Autores principales:	Liebl, M, Masud, F, Bostan, F, Chi, E, Pass, S, Stuebing, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095434/ http://dx.doi.org/10.1186/cc5541

Ejemplares similares

Recombinant activated factor VII for the treatment of bleeding in abdominal surgery and cardiac surgery
por: Michalska, G, et al.
Publicado: (2009)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

Factor VII for intractable bleeding after cardiac surgery
por: Kogan, A, et al.
Publicado: (2007)

Use of recombinant activated factor VII after paediatric cardiac surgery
por: Kharkin, A, et al.
Publicado: (2006)

Safety of activated recombinant factor VII in patients with circulatory assist devices
por: Schneider, AS, et al.
Publicado: (2009)

Efficacy of recombinant activated factor VII in the management of severe hemorrhage following cardiac surgery
por: Trecova, N, et al.
Publicado: (2006)

Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
por: Rossaint, R, et al.
Publicado: (2006)

Two years experience with low-dose recombined activated factor VII treatment of non-haemophilic patients
por: Michalska, G, et al.
Publicado: (2006)

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven(®)) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
por: Thabut, D, et al.
Publicado: (2004)

Recombinant activated factor VII: does it really save lives?
por: Edke, U
Publicado: (2009)

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage
por: Schneider, AS, et al.
Publicado: (2009)

Use of Low-Dose Recombinant Factor Ⅶa for Uncontrolled Perioperative Bleeding
por: Chang, Zhi-gang, et al.
Publicado: (2020)

Comparison of low- and high-dose recombinant activated factor VII for postcardiac surgical bleeding
por: Habib, Aly Makram
Publicado: (2016)

Evaluation of the role of recombinant activated factor VII (NovoSeven) as a rescue haemostatic therapy in postcardiopulmonary bypass surgical patients
por: Chen, Z, et al.
Publicado: (2007)

Analysis of the off-licence use of recombinant activated factor VII for patients with uncontrolled haemorrhage in a UK tertiary referral hospital
por: Spivey, M, et al.
Publicado: (2009)

Recombinant-activated factor VII in patients with uncontrolled bleeding: A retrospective observational analysis
por: Abuhasna, Said D., et al.
Publicado: (2012)

Prothrombin complex concentrate use in surgical patients: a retrospective analysis of efficacy and safety for coumarin reversal and bleeding management
por: Schick, KS, et al.
Publicado: (2008)

Effectiveness and safety of recombinant activated factor
por: Echarri González, G, et al.
Publicado: (2006)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery
por: Barua, Anupama, et al.
Publicado: (2011)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

Experience with a single dose of recombinant activated factor VII for the management of mild-to-moderate bleeds in haemophilia
por: ALMAGRO, D, et al.
Publicado: (2011)

Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
por: Klitgaard, Thomas, et al.
Publicado: (2006)

Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients
por: AlGahtani, Farjah H., et al.
Publicado: (2010)

Randomized comparison of fibrinogen concentrate versus cryoprecipitate for bleeding control in pediatric cardiac surgery (FICCS study)
por: Galas, F, et al.
Publicado: (2012)

Systematic and mandatory monitoring by the public health authorities – a novel approach to improve infection control and increase patient safety
por: Höller, C, et al.
Publicado: (2015)

Predictive genetic factors for bleeding in cardiac surgery patients with cardiopulmonary bypass
por: Iribarren Sarrias, J, et al.
Publicado: (2006)

The use of activated recombinant coagulation factor VII in patients undergoing major reconstruction surgery for traumatic fracture pelvis or pelvis and acetabulum: a double-blind, randomised, placebo-controlled trial
por: Raobaikady, R, et al.
Publicado: (2005)

Right coronary artery stenting as treatment of postoperative bleeding after cardiac surgery
por: Alvarez, J Rubio, et al.
Publicado: (2013)

Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders
por: Johansson, Pär I, et al.
Publicado: (2010)

Use of recombinant activated factor VII for bleeding following resection of mediastinal angiosarcoma
por: Arora, D, et al.
Publicado: (2011)

The role of recombinant activated factor VII in cardiac surgery
por: Richardson, A, et al.
Publicado: (2009)

Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation
por: Hollis, Allison L., et al.
Publicado: (2016)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Pharmacokinetics, safety and tolerability of human recombinant alkaline phosphatase in healthy volunteers
por: Peters, E, et al.
Publicado: (2015)

Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy
por: Nicosia, Dario, et al.
Publicado: (2019)

Safety and accuracy of cardiac magnetic resonance imaging combined with low-dose dobutamine stress-testing in patients with congenital heart disease
por: Luijnenburg, Saskia E, et al.
Publicado: (2009)

Efficacy and safety of a device for minimally invasive direct cardiac masage
por: Timerman, S, et al.
Publicado: (2004)

Could the combination of bleeding time and platelet function predict the perioperative transfusion requirements in cardiac surgery patients?
por: Kataphigioti, M, et al.
Publicado: (2007)

P107 Safety and Efficacy of Tranexamic Acid to Minimise Perioperative Bleeding in Extrahepatic Abdominal Surgery: a systematic review and meta-analysis
por: Koh, Amanda, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_caa51ctp3apb00ht7s3k8np6qm